These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36597426)

  • 21. An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.
    Isnardi CA; Schneeberger EE; Kreimer JL; Luna PC; Echeverría C; Roberts K; de la Vega MC; Virasoro BM; Landi M; Quintana R; Exeni MED; Kogan N; Petkovic I; Pereira D; De Los Ángeles Correa M; Zelaya MD; Tissera Y; Elkin MSG; Pisoni CN; Alonso C; Cogo AK; Cosatti MA; García L; Retamozo C; de Los Ángeles Severina M; Nieto RE; Rosemffet M; Mussano E; Bertoli A; Savio VG; Cosentino V; Pons-Estel GJ
    Clin Rheumatol; 2022 Oct; 41(10):3199-3209. PubMed ID: 35760939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A global survey in the developmental landscape of possible vaccination strategies for COVID-19.
    Gasmi A; Srinath S; Dadar M; Pivina L; Menzel A; Benahmed AG; Chirumbolo S; Bjørklund G
    Clin Immunol; 2022 Apr; 237():108958. PubMed ID: 35218966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 Vaccines Breakthrough Infections and Adverse Effects Reported by the Birzeit University Community in Palestine.
    Abukhalil AD; Abushehadeh RR; Shatat SS; Al-Shami N; Naseef HA; Ladadweh H; Madia R
    Int J Gen Med; 2024; 17():3349-3360. PubMed ID: 39100722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary-the HUN-VE study.
    Vokó Z; Kiss Z; Surján G; Surján O; Barcza Z; Pályi B; Formanek-Balku E; Molnár GA; Herczeg R; Gyenesei A; Miseta A; Kollár L; Wittmann I; Müller C; Kásler M
    Clin Microbiol Infect; 2022 Mar; 28(3):398-404. PubMed ID: 34838783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Side Effects and Efficacy of COVID-19 Vaccines among the Egyptian Population.
    Elgendy MO; El-Gendy AO; Mahmoud S; Mohammed TY; Abdelrahim MEA; Sayed AM
    Vaccines (Basel); 2022 Jan; 10(1):. PubMed ID: 35062770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term Side Effects of COVID-19 Vaccines (Astrazeneca, Sputnik-V, and Sinopharm) in Health Care Workers: A Cross-Sectional Study in Iran.
    Azimi-Nezhad M; Gholami A; Taghiabadi E; Ghodsi H
    Med J Islam Repub Iran; 2022; 36():159. PubMed ID: 36721491
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview.
    Shiravi AA; Ardekani A; Sheikhbahaei E; Heshmat-Ghahdarijani K
    Cardiol Ther; 2022 Mar; 11(1):13-21. PubMed ID: 34845662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of post-vaccination immunoglobulin G antibodies and T-cell immune response after inoculation with different types and doses of SARS-CoV-2 vaccines: A retrospective cohort study.
    Al-Rifai RH; Alhosani F; Abuyadek R; Atef S; Donnelly JG; Leinberger-Jabari A; Ahmed LA; Altrabulsi B; Alatoom A; Alsuwaidi AR; AbdelWareth L
    Front Med (Lausanne); 2022; 9():1092646. PubMed ID: 36703898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Personalized predictions of adverse side effects of the COVID-19 vaccines.
    Jamshidi E; Asgary A; Kharrazi AY; Tavakoli N; Zali A; Mehrazi M; Jamshidi M; Farrokhi B; Maher A; von Garnier C; Rahi SJ; Mansouri N
    Heliyon; 2023 Jan; 9(1):e12753. PubMed ID: 36597482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Humoral and Cellular Immunogenicity of Six Different Vaccines against SARS-CoV-2 in Adults: A Comparative Study in Tunisia (North Africa).
    Ben Ahmed M; Bellali H; Gdoura M; Zamali I; Kallala O; Ben Hmid A; Hamdi W; Ayari H; Fares H; Mechri K; Marzouki S; Triki H; Ben Alaya N; Chahed MK; Klouz A; Sebai Ben Amor S; Ben Rayana C; Razgallah Khrouf M; Hamouda C; Elkadri N; Daghfous R; Trabelsi A
    Vaccines (Basel); 2022 Jul; 10(8):. PubMed ID: 35893838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the long-stand antibody response induced by COVID-19 vaccines: A study in an educational cohort in San Luis, Argentina.
    Eliçabe RJ; Distel MN; Jofré BL; Leporati M; Silva JE; Arias JL; Gorlino CV; Funes SC; Velazquez M; Vitale P; Davicino RC; Di Genaro MS
    Vaccine; 2023 Jan; 41(2):476-485. PubMed ID: 36481109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unfolding the Mild to Moderate Short-Term Side Effects of Four COVID-19 Vaccines Used in Bahrain: A Cross-Sectional Study.
    Zahid MN
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential Adverse Effects of COVID-19 Vaccines on Iranian Healthcare Workers: Comparison of Four Available Vaccines in Tehran: A Retrospective Cross-sectional Study.
    Abdollahi A; Naseh I; Kalroozi F; Kazemi-Galougahi MH; Nezamzadeh M; Qorbanzadeh A; Ameri R; Taghavi H; Zoshk MY
    Oman Med J; 2023 Mar; 38(2):e486. PubMed ID: 37168286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Side Effects Associated With Homologous and Heterologous COVID-19 Vaccines: A Cross-Sectional Study in Saudi Arabia.
    Mohammed RA; Yazbik RS; Baajajah LH; Alharthy SF; Alsalahi H; Mahjaa MA; Barakat MM; Badawy MI; Sultan I
    Cureus; 2023 Jan; 15(1):e34030. PubMed ID: 36814743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overt Hypothyroidism Status Post Pfizer-BioNTech Vaccination: A Case Study.
    Nandennagari S; Annam P; Naidu N; Vegesna P; Bethala K
    Cureus; 2023 Jun; 15(6):e41180. PubMed ID: 37525806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Comprehensive Review on Various Aspects of SARS-CoV-2 (COVID-19) Vaccines.
    Pordanjani SR; Pordanjani AR; Askarpour H; Arjmand M; Babakhanian M; Amiri M; Mazaheri E
    Int J Prev Med; 2022; 13():151. PubMed ID: 36911005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humoral immunogenicity of COVID-19 vaccines in patients with inflammatory rheumatic diseases under treatment with Rituximab: a case-control study (COVID-19VacRTX).
    Schumacher F; Mrdenovic N; Scheicht D; Pons-Kühnemann J; Scheibelhut C; Strunk J
    Rheumatology (Oxford); 2022 Oct; 61(10):3912-3918. PubMed ID: 35094050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Against the Delta Variant.
    Risk M; Shen C; Hayek SS; Holevinski L; Schiopu E; Freed G; Akin C; Zhao L
    Clin Infect Dis; 2022 Aug; 75(1):e623-e629. PubMed ID: 35137006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
    Self WH; Tenforde MW; Rhoads JP; Gaglani M; Ginde AA; Douin DJ; Olson SM; Talbot HK; Casey JD; Mohr NM; Zepeski A; McNeal T; Ghamande S; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Gong MN; Mohamed A; Henning DJ; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Exline MC; Halasa N; Chappell JD; Lauring AS; Grijalva CG; Rice TW; Jones ID; Stubblefield WB; Baughman A; Womack KN; Lindsell CJ; Hart KW; Zhu Y; Mills L; Lester SN; Stumpf MM; Naioti EA; Kobayashi M; Verani JR; Thornburg NJ; Patel MM;
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(38):1337-1343. PubMed ID: 34555004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety Profile of COVID-19 Vaccines among Healthcare Workers in Poland.
    Paczkowska A; Hoffmann K; Michalak M; Hans-Wytrychowska A; Bryl W; Kopciuch D; Zaprutko T; Ratajczak P; Nowakowska E; Kus K
    Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.